Orlando, FL – PRIUM, a medical intervention company specializing in reducing the inappropriate use of prescription drugs, recently announced its ground-breaking TaperRx service at the Workers’ Compensation Institute’s Educational Conference.
“TaperRx provides physicians a ‘roadmap’ to assist them in reducing or eliminating the numerous prescription drugs in multiple classifications that chronic pain patients typically take,” said PRIUM Senior Vice President Mark Pew.
These drugs often include opioids, non-steroidal anti-inflammatories, benzodiazepines, muscle relaxants, and/or anti-depressants. Weaning patients off a mix of drug classifications is complicated because different drugs require different tapering protocols. Physicians need to decide which drugs to taper first, how to reduce their dosage, and what milestones to meet before moving to the next step.
PRIUM’s white paper, “An Analysis of Drug Therapy Tapering Guidelines” showed that no clinical guidelines address how to wean patients from multiple drugs in multiple classifications. The white paper is available here. TaperRx was developed to help provide clinical clarity to that process.
Using the best available science, PRIUM’s pharmacological and medical experts developed and oversee TaperRx, which delivers a detailed tapering roadmap customized to the patient’s unique drug regimen, physiological and psychosocial circumstances. TaperRx suggests a personalized tapering strategy with step-by-step recommendations, providing a clinical rationale for each.
“This is the healthcare industry’s first service to aggregate the best tapering evidence available to affect change in a complex drug regimen,” Pew said. “TaperRx augments the physician’s expertise, enables accountability and facilitates communication among the physician, patient and payer throughout the weaning process.”
Source: PRIUM/King Knight